Is 2,4,6-Tris(dimethylamino)-1,3,5-triazine Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use 2,4,6-Tris(dimethylamino)-1,3,5-triazine? Is 2,4,6-Tris(dimethylamino)-1,3,5-triazine safe for nursing mother and child? Does 2,4,6-Tris(dimethylamino)-1,3,5-triazine extracts into breast milk? Does 2,4,6-Tris(dimethylamino)-1,3,5-triazine has any long term or short term side effects on infants? Can 2,4,6-Tris(dimethylamino)-1,3,5-triazine influence milk supply or can 2,4,6-Tris(dimethylamino)-1,3,5-triazine decrease milk supply in lactating mothers?
2,4,6-Tris(dimethylamino)-1,3,5-triazine lactation summary
- DrLact safety Score for 2,4,6-Tris(dimethylamino)-1,3,5-triazine is 7 out of 8 which is considered Dangerous as per our analyses.
- A safety Score of 7 indicates that usage of 2,4,6-Tris(dimethylamino)-1,3,5-triazine may cause toxic or severe side effects in breastfed baby.
- Our study of different scientific research indicates that 2,4,6-Tris(dimethylamino)-1,3,5-triazine may cause moderate to high side effects or may affect milk supply in lactating mother.
- Our suggestion is to use safer alternate options rather than using 2,4,6-Tris(dimethylamino)-1,3,5-triazine .
- Usage of 2,4,6-Tris(dimethylamino)-1,3,5-triazine is in contradiction to breastfeeding hence if it is must to use 2,4,6-Tris(dimethylamino)-1,3,5-triazine and there is no better alternative available then breastfeeding shall be stopped permanently or temporarily.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About 2,4,6-Tris(dimethylamino)-1,3,5-triazine usage in lactation
Drug is cleared from the body in 6 elimination half-lives. Resuming breastfeeding is likely safe after 3 pump-and-dump days. Regular milk expression and disposition to keep production and avoiding breast plethora or mastitis is desirable.
Alternate Drugs for Antineoplastic agents. ATC L01
Busulfan(Dangerous)
Cisplatin(Unsafe)
Cyclophosphamide(Dangerous)
Doxorubicin(Dangerous)
Etoposide(Dangerous)
Hydroxyurea(Low Risk)
Mercaptopurine(Safe)
Mitoxantrone(Dangerous)
Vincristine(Dangerous)
Methotrexate(Low Risk)
Imatinib(Unsafe)
Trastuzumab(Unsafe)
Bevacizumab(Low Risk)
Rituximab(Low Risk)
Alemtuzumab(Low Risk)
Fluorouracil(Dangerous)
Paclitaxel(Dangerous)
Carboplatin(Dangerous)
Cetuximab(Unsafe)
Brentuximab Vedotin(Low Risk)
Ipilimumab(Unsafe)
Everolimus(Unsafe)
Thioguanine(Dangerous)
Dacarbazine(Dangerous)
Vinorelbine(Dangerous)
Bleomycin(Dangerous)
Vinblastine(Dangerous)
Nivolumab(Unsafe)
Nilotinib(Unsafe)
Dasatinib(Unsafe)
Cladribine(Dangerous)
Erlotinib(Unsafe)
Pazopanib(Unsafe)
Capecitabine(Dangerous)
Docetaxel(Dangerous)
Carmustine(Dangerous)
Exemestane(Dangerous)
Gemcitabine(Dangerous)
Dactinomycin(Dangerous)
Epirubucin(Dangerous)
Fluorouracil Topical Solution(Low Risk)
Idarubicin-Hcl(Dangerous)
Ifosfamide(Dangerous)
Melphalan(Dangerous)
Mitomycin(Dangerous)
Oxaliplatin(Dangerous)
Pentostatin(Dangerous)
Procarbazine(Dangerous)
Teniposide(Dangerous)
Thiotepa(Dangerous)
Tretinoin Oral(Dangerous)
Vinorelbine Tartrate(Dangerous)
Imatinib Mesilate(Unsafe)
Altretamine(Dangerous)
Aminoglutethimide(Dangerous)
5-Aminolevulinic Acid(Low Risk)
Hydroxycarbamide(Low Risk)
Anastrozole(Dangerous)
Arsenic-Trioxide(Dangerous)
Asparaginase(Dangerous)
Bexarotene(Dangerous)
Cytarabine(Dangerous)
Chlorambucil(Dangerous)
Chlormethine(Dangerous)
Daunorubicin(Dangerous)
Rubidomycin(Dangerous)
Amethopterin(Low Risk)
Vincaleukoblastine(Dangerous)
Doxorubicin Hydrochloride(Dangerous)
Vlb(Dangerous)
Mechlorethamine(Dangerous)
Platinum Diamminodichloride(Unsafe)
4-Amino-10-methylfolic Acid(Low Risk)
5-ALA(Low Risk)
5-Fu(Dangerous)
6-Mercaptopurine(Safe)
6-Thiohypoxanthine(Safe)
6-Thioxopurine(Safe)
MTX(Low Risk)
Cytosine Arabinoside(Dangerous)
Daunomycin(Dangerous)
Actinomycin D(Dangerous)
Deoxycoformycin(Dangerous)